Cutaneous porphyrias part II: treatment strategies
Identifieur interne : 000092 ( Istex/Curation ); précédent : 000091; suivant : 000093Cutaneous porphyrias part II: treatment strategies
Auteurs : Suzanne Tintle [États-Unis] ; Ali Alikhan [États-Unis] ; Mary E. Horner [États-Unis] ; Jennifer L. Hand [États-Unis] ; Dawn Marie R. Davis [États-Unis]Source :
- International Journal of Dermatology [ 0011-9059 ] ; 2014-01.
Abstract
The porphyrias are diverse in pathophysiology, clinical presentation, severity, and prognosis, presenting a diagnostic and therapeutic challenge. Although not easily curable, the dermatological manifestations of these diseases, photosensitivity and associated cutaneous pathology, can be effectively prevented and managed. Sun avoidance is essential, and patient education regarding the irreversibility of photocutaneous damage is a necessary corollary. Beyond preventative measures, the care of fragile, vulnerable skin, and pain management, each of the porphyrias has a limited number of unique additional therapeutic options. Many of the treatments have been published only in small case series or anecdotal reports and do not have well‐understood nor proven mechanisms of action. This article presents a comprehensive review of available therapeutic options and long‐term management recommendations for the cutaneous porphyrias.
Url:
DOI: 10.1111/ijd.12016
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000092
Links to Exploration step
ISTEX:A5D9A929E99FC3B0A392C790C8B83C43C2B7018FLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cutaneous porphyrias part II: treatment strategies</title><author><name sortKey="Tintle, Suzanne" sort="Tintle, Suzanne" uniqKey="Tintle S" first="Suzanne" last="Tintle">Suzanne Tintle</name><affiliation wicri:level="1"><mods:affiliation>Department of Dermatology, Tufts Medical Center, MA, Boston, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Dermatology, Tufts Medical Center, MA, Boston</wicri:regionArea></affiliation></author><author><name sortKey="Alikhan, Ali" sort="Alikhan, Ali" uniqKey="Alikhan A" first="Ali" last="Alikhan">Ali Alikhan</name><affiliation wicri:level="1"><mods:affiliation>Department of Dermatology, Mayo Clinic, MN, Rochester, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Dermatology, Mayo Clinic, MN, Rochester</wicri:regionArea></affiliation><affiliation wicri:level="2"><mods:affiliation>Ali Alikhan, Department of Dermatology, Mayo Clinic200 First Street SWRochesterMN 55905USAE‐mail: </mods:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Minnesota</region></placeName><wicri:cityArea>Ali Alikhan, Department of Dermatology</wicri:cityArea></affiliation><affiliation wicri:level="1"><mods:affiliation>E-mail: alikhan.mirza@mayo.edu</mods:affiliation><country wicri:rule="url">États-Unis</country></affiliation></author><author><name sortKey="Horner, Mary E" sort="Horner, Mary E" uniqKey="Horner M" first="Mary E." last="Horner">Mary E. Horner</name><affiliation wicri:level="1"><mods:affiliation>Department of Dermatology, Baylor University Medical Center, TX, Dallas, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Dermatology, Baylor University Medical Center, TX, Dallas</wicri:regionArea></affiliation></author><author><name sortKey="Hand, Jennifer L" sort="Hand, Jennifer L" uniqKey="Hand J" first="Jennifer L." last="Hand">Jennifer L. Hand</name><affiliation wicri:level="1"><mods:affiliation>Department of Dermatology, Mayo Clinic, Rochester, MN, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Dermatology, Mayo Clinic, Rochester, MN</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Pediatrics, Mayo Clinic, Rochester, MN, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Pediatrics, Mayo Clinic, Rochester, MN</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Medical Genetics, Mayo Clinic, MN, Rochester, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medical Genetics, Mayo Clinic, MN, Rochester</wicri:regionArea></affiliation></author><author><name sortKey="Davis, Dawn Marie R" sort="Davis, Dawn Marie R" uniqKey="Davis D" first="Dawn Marie R." last="Davis">Dawn Marie R. Davis</name><affiliation wicri:level="1"><mods:affiliation>Department of Dermatology, Mayo Clinic, Rochester, MN, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Dermatology, Mayo Clinic, Rochester, MN</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Pediatrics, Mayo Clinic, MN, Rochester, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Pediatrics, Mayo Clinic, MN, Rochester</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A5D9A929E99FC3B0A392C790C8B83C43C2B7018F</idno><date when="2014" year="2014">2014</date><idno type="doi">10.1111/ijd.12016</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-91PB24JN-N/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000092</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000092</idno><idno type="wicri:Area/Istex/Curation">000092</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Cutaneous porphyrias part II: treatment strategies</title><author><name sortKey="Tintle, Suzanne" sort="Tintle, Suzanne" uniqKey="Tintle S" first="Suzanne" last="Tintle">Suzanne Tintle</name><affiliation wicri:level="1"><mods:affiliation>Department of Dermatology, Tufts Medical Center, MA, Boston, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Dermatology, Tufts Medical Center, MA, Boston</wicri:regionArea></affiliation></author><author><name sortKey="Alikhan, Ali" sort="Alikhan, Ali" uniqKey="Alikhan A" first="Ali" last="Alikhan">Ali Alikhan</name><affiliation wicri:level="1"><mods:affiliation>Department of Dermatology, Mayo Clinic, MN, Rochester, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Dermatology, Mayo Clinic, MN, Rochester</wicri:regionArea></affiliation><affiliation wicri:level="2"><mods:affiliation>Ali Alikhan, Department of Dermatology, Mayo Clinic200 First Street SWRochesterMN 55905USAE‐mail: </mods:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Minnesota</region></placeName><wicri:cityArea>Ali Alikhan, Department of Dermatology</wicri:cityArea></affiliation><affiliation wicri:level="1"><mods:affiliation>E-mail: alikhan.mirza@mayo.edu</mods:affiliation><country wicri:rule="url">États-Unis</country></affiliation></author><author><name sortKey="Horner, Mary E" sort="Horner, Mary E" uniqKey="Horner M" first="Mary E." last="Horner">Mary E. Horner</name><affiliation wicri:level="1"><mods:affiliation>Department of Dermatology, Baylor University Medical Center, TX, Dallas, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Dermatology, Baylor University Medical Center, TX, Dallas</wicri:regionArea></affiliation></author><author><name sortKey="Hand, Jennifer L" sort="Hand, Jennifer L" uniqKey="Hand J" first="Jennifer L." last="Hand">Jennifer L. Hand</name><affiliation wicri:level="1"><mods:affiliation>Department of Dermatology, Mayo Clinic, Rochester, MN, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Dermatology, Mayo Clinic, Rochester, MN</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Pediatrics, Mayo Clinic, Rochester, MN, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Pediatrics, Mayo Clinic, Rochester, MN</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Medical Genetics, Mayo Clinic, MN, Rochester, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medical Genetics, Mayo Clinic, MN, Rochester</wicri:regionArea></affiliation></author><author><name sortKey="Davis, Dawn Marie R" sort="Davis, Dawn Marie R" uniqKey="Davis D" first="Dawn Marie R." last="Davis">Dawn Marie R. Davis</name><affiliation wicri:level="1"><mods:affiliation>Department of Dermatology, Mayo Clinic, Rochester, MN, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Dermatology, Mayo Clinic, Rochester, MN</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Pediatrics, Mayo Clinic, MN, Rochester, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Pediatrics, Mayo Clinic, MN, Rochester</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">International Journal of Dermatology</title><title level="j" type="alt">INTERNATIONAL JOURNAL OF DERMATOLOGY</title><idno type="ISSN">0011-9059</idno><idno type="eISSN">1365-4632</idno><imprint><biblScope unit="vol">53</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="3">3</biblScope><biblScope unit="page" to="24">24</biblScope><biblScope unit="page-count">22</biblScope><date type="published" when="2014-01">2014-01</date></imprint><idno type="ISSN">0011-9059</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0011-9059</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">The porphyrias are diverse in pathophysiology, clinical presentation, severity, and prognosis, presenting a diagnostic and therapeutic challenge. Although not easily curable, the dermatological manifestations of these diseases, photosensitivity and associated cutaneous pathology, can be effectively prevented and managed. Sun avoidance is essential, and patient education regarding the irreversibility of photocutaneous damage is a necessary corollary. Beyond preventative measures, the care of fragile, vulnerable skin, and pain management, each of the porphyrias has a limited number of unique additional therapeutic options. Many of the treatments have been published only in small case series or anecdotal reports and do not have well‐understood nor proven mechanisms of action. This article presents a comprehensive review of available therapeutic options and long‐term management recommendations for the cutaneous porphyrias.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000092 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000092 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:A5D9A929E99FC3B0A392C790C8B83C43C2B7018F
|texte= Cutaneous porphyrias part II: treatment strategies
}}
| This area was generated with Dilib version V0.6.33. |  |